Oxford PV Signs Strategic Licensing Agreement with First Solar, Inc.
First Solar has secured access to Oxford PV’s perovskite IP portfolio for use across US utility-scale, commercial & industrial and residential solar markets.
First Solar has secured access to Oxford PV’s perovskite IP portfolio for use across US utility-scale, commercial & industrial and residential solar markets.
OTIF is pleased to have led a £1m investment in Panda Surgical, a next-generation neurosurgical robotics company emerging from University College London. This investment underscores our commitment to backing advanced life-science ventures with strong intellectual property and high-impact potential.
Launch of Quantum-AI Data Centre is a flagship initiative of the UK–US Tech Trade Partnership announced by President Trump and Prime Minister Starmer
The acquisition will see Brill Power technology incorporated into PETL BESS systems immediately to provide world leading BESS solutions.
OTIF participated in a £5m investment supporting the combined venture, alongside FirstGroup plc, Barclays Climate Ventures and Oxford University.
We are delighted that OTIF Ventures portfolio company OrganOx has accepted an acquisition offer by Terumo Medical Corporation, a leading global medical technology company headquartered in Japan, in a transaction valued at $1.5 billion USD.
This reflects a 12x multiple from the first OTIF investment in 2016.